Novo Nordisk A/S (NVO)
39.70
-1.00
(-2.46%)
USD |
NYSE |
Nov 18, 16:00
39.52
-0.18
(-0.45%)
After-Hours: 20:00
Novo Nordisk Price : 39.70 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 40.72 | 40.96 | 40.23 | 40.70 | 17.84M |
| Nov 16, 2026 | 42.05 | 42.30 | 41.44 | 41.60 | 16.66M |
| Nov 13, 2026 | 40.97 | 41.80 | 40.64 | 41.63 | 11.71M |
| Nov 12, 2026 | 40.93 | 41.01 | 40.08 | 40.65 | 15.75M |
| Nov 11, 2026 | 40.50 | 41.20 | 40.10 | 41.09 | 11.71M |
| Nov 10, 2026 | 40.71 | 40.81 | 40.38 | 40.70 | 6.531M |
| Nov 09, 2026 | 41.14 | 41.63 | 40.55 | 41.38 | 11.76M |
| Nov 06, 2026 | 39.76 | 40.55 | 39.53 | 40.31 | 9.237M |
| Nov 05, 2026 | 41.16 | 41.18 | 39.99 | 40.30 | 18.50M |
| Nov 04, 2026 | 42.45 | 43.24 | 42.12 | 42.18 | 26.04M |
| Nov 03, 2026 | 40.34 | 40.63 | 39.96 | 40.19 | 12.22M |
| Nov 02, 2026 | 40.10 | 40.78 | 40.06 | 40.45 | 11.18M |
| Oct 30, 2026 | 39.61 | 40.10 | 39.54 | 40.00 | 15.28M |
| Oct 29, 2026 | 38.67 | 39.22 | 38.56 | 39.14 | 10.44M |
| Oct 28, 2026 | 38.11 | 38.54 | 37.96 | 38.29 | 11.36M |
| Oct 27, 2026 | 38.58 | 39.02 | 38.54 | 38.67 | 6.776M |
| Oct 26, 2026 | 39.02 | 39.24 | 38.67 | 39.13 | 8.042M |
| Oct 23, 2026 | 39.21 | 39.29 | 38.75 | 39.05 | 9.188M |
| Oct 22, 2026 | 39.39 | 39.76 | 39.24 | 39.43 | 8.561M |
| Oct 21, 2026 | 39.25 | 39.49 | 39.05 | 39.06 | 6.803M |
| Oct 20, 2026 | 38.92 | 39.38 | 38.81 | 39.35 | 9.413M |
| Oct 19, 2026 | 38.65 | 38.84 | 38.35 | 38.42 | 7.453M |
| Oct 16, 2026 | 39.33 | 39.40 | 38.67 | 38.83 | 10.82M |
| Oct 15, 2026 | 38.99 | 39.68 | 38.89 | 39.22 | 14.78M |
| Oct 14, 2026 | 37.90 | 38.42 | 37.90 | 38.12 | 9.364M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 178.82 |
| GSK Plc | 48.58 |
| Johnson & Johnson | 273.98 |
| Eli Lilly & Co. | 1382.64 |
| Merck & Co., Inc. | 138.48 |
Price Related Metrics
| PE Ratio | 10.00 |
| PS Ratio | 3.396 |
| PEG Ratio | 0.6451 |
| Price to Book Value | 5.303 |
| Price to Free Cash Flow | 25.26 |
| Earnings Yield | 10.00% |
| Market Cap | 132.83B |
| PEGY Ratio | 0.5022 |
| Operating PE Ratio | 7.023 |
| Normalized PE Ratio | 9.028 |